ADIMMUNE CORPORATION — Investor Relations & Filings
ADIMMUNE CORPORATION, established in 1965, specializes in the research, development, and large-scale manufacturing of human vaccines and biologics. The company is a primary supplier of seasonal influenza and tetanus vaccines, maintaining production facilities that adhere to PIC/S GMP, US FDA, and EU standards. Its operations encompass the full product lifecycle, from initial R&D to commercial distribution. In addition to its proprietary vaccine portfolio, the company provides Contract Development and Manufacturing Organization (CDMO) services, supporting collaborative development and global supply chains. Recognized for its technical expertise in viral and bacterial vaccine production, the organization focuses on delivering high-quality immunization solutions to international markets while leveraging its history as a pioneering vaccine laboratory.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 113年度存貨週轉率 | 2025-03-17 | Chinese | |
| 113年度毛利率 | 2025-03-17 | Chinese | |
| 公告本公司董事會通過113年度合併財務報告 | 2025-03-12 | Chinese | |
| 董事會決議不分派股利 | 2025-03-12 | Chinese | |
| 113年度股利金額(董事會決議) | 2025-03-12 | Chinese | |
| 公告本公司董事會決議召開114年股東常會日期及相關事宜 | 2025-03-12 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 34544783 | 113年度存貨週轉率 | 2025-03-17 | Chinese | ||
| 34544780 | 113年度毛利率 | 2025-03-17 | Chinese | ||
| 34544799 | 公告本公司董事會通過113年度合併財務報告 | 2025-03-12 | Chinese | ||
| 34544803 | 董事會決議不分派股利 | 2025-03-12 | Chinese | ||
| 34544806 | 113年度股利金額(董事會決議) | 2025-03-12 | Chinese | ||
| 34544810 | 公告本公司董事會決議召開114年股東常會日期及相關事宜 | 2025-03-12 | Chinese | ||
| 34544816 | 114年2月營業收入 | 2025-03-10 | Chinese | ||
| 34544814 | 114年2月背書保證與資金貸與 | 2025-03-10 | Chinese | ||
| 34544823 | 114年02月董事會成員及持股 | 2025-03-05 | Chinese | ||
| 34544818 | 114年02月內部人持股異動(事後) | 2025-03-05 | Chinese | ||
| 34544825 | 公告本公司民國113年度財務報告董事會召開日期 | 2025-03-03 | Chinese | ||
| 34544829 | 114年1月背書保證與資金貸與 | 2025-02-10 | Chinese | ||
| 34544827 | 114年1月營業收入 | 2025-02-10 | Chinese | ||
| 34544836 | 114年01月內部人持股異動(事後) | 2025-02-07 | Chinese | ||
| 34544832 | 114年01月董事會成員及持股 | 2025-02-07 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
ADIMMUNE CORPORATION via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/52386/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=52386 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=52386 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=52386 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 52386}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ADIMMUNE CORPORATION (id: 52386)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.